Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions

Current Opinion in Microbiology

Volumn 1, Issue 4, 1998, Pages 455-460

  Mottram, Jeremy C ^a   Brooks, Darren R ^a   Coombs, Graham H ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR;

ANIMAL; DRUG EFFECT; ENZYMOLOGY; GENETICS; HOST PARASITE INTERACTION; IMMUNOLOGY; LEISHMANIA; METABOLISM; PARASITOLOGY; PATHOGENICITY; REVIEW; TRYPANOSOMA; VERTEBRATE;

ANIMALS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HOST-PARASITE RELATIONS; LEISHMANIA; TRYPANOSOMA; VERTEBRATES;

EID: 0032129794     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(98)80065-9     Document Type: Article

References (47)

1. Coombs GH, Mottram JC: Parasite proteinases and amino acid metabolism: possibilities for chemotherapeutic exploitation. Parasitology 1997, 114:S61-S80.
2. Coombs GH, Mottram JC: Proteinases of trypanosomes and Leishmania. In Trypanosomiasis and Leishmaniasis: Biology and Control. Edited by Hide G, Mottram JC, Coombs GH, Holmes PH. Oxford: CAB International; 1997:177-197.
3. Mottram JC, Frame MJ, Brooks DR, Tetley L, Hutchison JE, Souza AE, Coombs GH: The multiple cpb cysteine proteinase genes of Leishmania mexicana encode isoenzymes which differ in their stage-regulation and substrate preferences. J Biol Chem 1997, 272:14285-14293. In this paper six of the 19 cpb genes were analysed for sequence variation and expression profiles in different life-cycle stages. Genes 1 and 2, which lack the characteristic carboxy-terminal extension, were expressed in the infective metacyclic stage, whereas the remaining genes in the array, which contain the carboxy-terminal extension, were amastigote specific. Individual isoenzymes re-expressed in a cpb null mutant were found to vary in substrate specificity and ability to restore loss of virulence associated with the null mutant.
4. Lima APCA, Tessier DC, Thomas DY, Scharfstein J, Storer AC, Vernet T: Identification of new cysteine protease gene isoforms in Trypanosoma cruzi. Mol Biochem Parasitol 1994, 67:333-338.
5. Martinez J, Henriksson J, Ridaker M, Pettersson U, Cazzulo JJ: Polymorphisms of the genes encoding cruzipain, the major cysteine proteinase of Trypanosoma cruzi, in the region encoding the C-terminal domain. FEMS Microbiol Lett 1998, 159:35-39.
6. Mottram JC, Robertson CD, Coombs GH, Barry JD: A developmentally regulated cysteine proteinase gene of Leishmania mexicana. Mol Microbiol 1992, 6:1925-1932.
7. Traub-Cseko YM, Duboise M, Boukai LK, McMahon-Pratt D: Identification of two distinct cysteine proteinase genes of Leishmania pifanoi axenic amastigotes using the polymerase chain reaction. Mol Biochem Parasitol 1993, 57:101-116.
8. Omara-Opyene AL, Gedamu L: Molecular cloning, characterization and overexpression of two distinct cysteine protease cDNAs from Leishmania donovani chagasi. Mol Biochem Parasitol 1997, 90:247-267.
9. Bart G, Coombs GH, Mottram JC: Isolation of lmcpc, a gene encoding a Leishmania mexicana cathepsin B-like cysteine proteinase. Mol Biochem Parasitol 1995, 73:271-274.
10. Sakanari JA, Nadler SA, Chan VJ, Engel JC, Leptak C, Bouvier J: Leishmania major: Comparison of the cathepsin L- and B-like cysteine protease genes with those of other trypanosomatids. Exp Parasitol 1997, 85:63-76.
11. Garcia MP, Nobrega OT, Teixeira ARL, Sousa MV, Santana JM: Characterisation of a Trypanosoma cruzi acidic 30 kDa cysteine protease. Mol Biochem Parasitol 1998, 91:263-272.
12. Tomas AM, Miles MA, Kelly JM: Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis. Eur J Biochem 1997, 244:596-603. T. cruzi epimastigotes, when transfected with cosmid clones containing about 20 copies of the cruzipain gene, were found to over-express cysteine proteinase activity. This upregulation was maintained throughout the life-cycle with the enzyme found in vesicles of the endosomal/lysosomal system in epimastigotes, but also detected on the cell surface of the amastigote. Phenotypic analysis showed that the transformed parasites had an enhanced ability to undergo metacyclogenesis.
13. Souza AE, Bates PA, Coombs GH, Mottram JC: Null mutants for the lmcpa cysteine proteinase gene in Leishmania mexicana. Mol Biochem Parasitol 1994, 63:213-220.
14. Bart G, Frame MJ, Carter R, Coombs GH, Mottram JC: Cathepsin B-like cysteine proteinase-deficient mutants of Leishmania mexicana. Mol Biochem Parasitol 1997, 88:53-61.
15. Mottram JC, Souza AE, Hutchison JE, Carter R, Frame MJ, Coombs GH: Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc Natl Acad Sci USA 1996, 93:6008-6013.
16. Cadena RD, Colman RW: Structure and functions of human kininogens. Trends Pharmacol Sci 1991, 12:272-275.
17. Irvine JW, Coombs GH, North MJ: Cystatin-like cysteine proteinase inhibitors of parasitic protozoa. FEMS Microbiol Lett 1992, 96:67-72.
18. Lonsdale-Eccles JD, Mpimbaza GWN, Nkhungulu ZM, Olobo J, Smith L, Tosomba OM, Grab DJ: Trypanosomatid cysteine protease activity may be enhanced by a kininogen-like moiety from host serum. Biochem J 1995, 305:549-556.
19. Wiser MF, Lonsdale-Eccles JD, D'Alessandro A, Grab DJ: A cryptic protease activity from Trypanosoma cruzi revealed by preincubation with kininogen at low temperatures. Biochem Biophys Res Commun 1997, 240:540-544.
20. Turk B, Stoka V, Turk V, Johansson G, Cazzulo JJ, Bjork I: High molecular weight kininogen binds 2 molecules of cysteine proteinases with different rate constants. FEBS Lett 1996, 391:109-112.
21. Coutinho CM, Cavalcanti GH, van Leuven F, AraujoJorge TC: Alpha-2-macroglobulin binds to the surface of Trypanosoma cruzi. Parasitol Res 1997, 83:144-150.
22. Nascimento AE, de Souza W: High resolution localization of cruzipain and Ssp4 in Trypanosoma cruzi by replica staining label fracture. Biol Cell 1996, 86:53-58.
23. Del Nery E, Juliano MA, Lima AA, Scharfstein J, Juliano L: Kininogenase activity by the major cysteinyl proteinase (Cruzipain) from Trypanosoma cruzi. J Biol Chem 1997, 272:25713-25718. The major cysteine proteinase of T. cruzi, cruzipain, isolated and purified from the parasite was found to cleave kininogen to generate Lys-bradykinin, a proinflammatory peptide. Interestingly, two recombinant cruzipain isoenzymes, cruzain and cruzipain 2, cleaved the bradykinin-flanking sites at markedly different rates. Neither of the two recombinant enzymes contain the characteristic carboxy-terminal extension and the authors tentatively propose that this domain may influence the enzymatic properties of cruzipain. It should be noted, however, that the enzyme purified from the parasite contains multiple isoenzymes derived from up to 40 gene copies. Differences in substrate specificity may therefore arise from isoenzymes transcribed from different copies within the cruzipain gene array.
24. Svensjo E, Cyrino FA, Juliano L, Scharfstein J: Plasma leakage induced in postcapillary venules by the major cysteine-proteinase from Trypanosoma cruzi and its modulation by H1-blocker mepyramin. Microvascular Research 1997, 54:93-97.
25. McKerrow JH, McGrath ME, Engel JC: The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design. Parasitol Today 1995, 11:279-282.
26. Robertson CD, Coombs GH, North MJ, Mottram JC: Parasite cysteine proteinases. Perspect Drug Disc Design 1996, 6:99-118.
27. Selzer PM, Chen XW, Chan VJ, Cheng MS, Kenyon GL, Kuntz ID, Sakanari JA, Cohen FE, McKerrow JH: Leishmania major: Molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors. Exp Parasitol 1997, 87:212-221. A model of the L. major cathespin L- and cathepsin B-like cysteine proteinases was constructed on the basis of the known crystal structure of other papain-family enzymes. Potential cysteine proteinase inhibitors were identified by computer searching using the program Dock3.5. Several compounds selected from this screen were found to inhibit greatly at concentrations as low as 50 μM. In a subsequent study these inhibitors were found to have potent anti-leishmanial activity both in vitro and in vivo (PM Selzer et al., personal communication).
28. Engel JC, Doyle PS, Palmer J, Hsieh I, Bainton DF, McKerrow J: Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. J Cell Sci 1998, 111:597-606. Treatment of T. cruzi with cysteine proteinase-specific inhibitors arrested cell growth and altered the intracellular location of cruzain by causing a build up in the Golgi compartment. The results suggest that the proteinase inhibitors prevent auto-catalytic processing of the enzyme resulting in an accumulation in the Golgi and causing a peripheral distention of the cisternae. This build up of pre-cursor parallels death of the epimastigote.
29. Mach L, Mort JS, Glössl J: Maturation of human procathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes. J Biol Chem 1994, 269:13030-13035.
30. Travis J, Potempa J, Maeda H: Are bacterial proteinases pathogenic factors. Trends Microbiol 1995, 3:405-407.
31. De Souza Leao S, Lang T, Prina E, Hellio R, Antoine J-C: Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J Cell Sci 1995, 108:3219-3231.
32. Finkelman FD, Urban JF: Cytokines making the right choice. Parasitol Today 1992, 8:311-314.
33. Barral A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR, Reed SG: Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci USA 1993, 90:3442-3446.
34. Reed SG: Cytokine control of the macrophage parasites Leishmania and Trypanosoma cruzi. In Molecular Approaches to Parasitotogy. Edited by Boothroyd JC, Komuniecki P. New York: Wiley-Liss; 1995:443-453.
35. Ilg T, Fuchs M, Gnau V, Wolfram M, Harbecke D, Overath P: Distribution of parasite cysteine proteinases in lesions of mice infected with Leishmania mexicana amastigotes. Mol Biochem Parasitol 1994, 67:193-203.
36. Troeberg L, Pike RN, Morty RE, Berry MK, Coetzer THT, Lonsdale-Eccles JD: Proteases from Trypanosoma brucei - Purification, characterisation and interactions with host regulatory molecules. Eur J Biochem 1996, 238:728-736.
37. Ramos A, Remedi MS, Sánchez C, Bonacci G, Vides MA, Chiabrando G: Inhibitory effects of human α2-macroglobulin on Trypanosoma cruzi epimastigote proteinases. Acta Trop 1997, 68:327-337.
38. Authié E: Trypanosomiasis and trypanotolerance in cattle: A role for congopain. Parasitol Today 1994, 10:360-364.
39. Gonzalez G, Sunnemark D, Orn A, Gronvik KO: Detection of cruzipain, the major cysteine proteinase from Trypanosoma cruzi and its C-terminal extension in biological fluids during experimental infection in mice. Scand J Immunol 1996, 44:122-128.
40. Gruppi A, Cerbán FM, Vottero-Cima E: Exoantigens from Trypanosoma cruzi contain cruzipain. Acta Trop 1997, 63:141-149.
41. Morrot A, Strickland DK, Higuchi MD, Reis M, Pedrosa R, Scharfstein J: Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional α2-macroglobulin receptor in antigen presentation by monocytes. Int Immunol 1997, 9:825-834.
42. Wolfram M, Ilg T, Mottram JC, Overath P: Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites. Eur J Immunol 1995, 25:1094-1100.
43. Soong L, Duboise SM, Kima P, McMahon-Pratt D: Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect Immun 1995, 63:3559-3566.
44. Beyrodt CGP, Pinto AR, Freymüller E, Barbiéri CL: Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model. Infect Immun 1997, 65:2052-2059. This study confirmed that leishmanial cysteine proteinases can induce a Th1-type immune response but importantly also showed that vaccinating BALB/c mice with the enzyme can provide protection against a subsequent challenge with L. amazonensis amastigotes.
45. Rafati S, Couty-Jouve S, Alimohammadian MH, Louis JA: Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis. Clin Exp Immunol 1997, 110:203-211.
46. Handman E: Leishmania vaccines: old and new. Parasitol Today 1997, 13:236-238.
47. McMahon-Pratt D, Kima PE, Soong L: Leishmania amastigote target antigens: the challenge of a stealthy intracellular parasite. Parasitol Today 1998, 14:31-34.